Patricia Campbell
University of Alberta
AntibodyImmunologyTransplantationDiabetes mellitusMedicine
What is this?
Publications 97
#1Anat R. Tambur (NU: Northwestern University)H-Index: 25
#2Patricia Campbell (U of A: University of Alberta)H-Index: 21
Last. Roslyn B. Mannon (UA: University of Alabama)H-Index: 38
view all 17 authors...
The purpose of the STAR 2019 Working Group was to build on findings from the initial STAR report to further clarify the expectations, limitations, perceptions, and utility of alloimmune assays that are currently in use or in development for risk assessment in the setting of organ transplantation. The goal was to determine the precision and clinical feasibility/utility of such assays in evaluating both memory and primary alloimmune risks. The process included a critical review of biologically dri...
#1Ngan N. Lam (U of C: University of Calgary)
#2Devon J. Boyne (U of C: University of Calgary)H-Index: 2
Last. Hude Quan (U of C: University of Calgary)H-Index: 58
view all 11 authors...
Background:Due to their history of renal disease and exposure to immunosuppression, kidney transplant recipients with a failing graft may be at higher risk of adverse outcomes compared to nontransp...
#1S. Chih (U of O: University of Ottawa)H-Index: 6
#2Michael McDonald (UHN: University Health Network)H-Index: 13
Last. R.A. Davey (UWO: University of Western Ontario)H-Index: 2
view all 24 authors...
Abstract Significant practice-changing developments have occurred in the care of heart transplantation candidates and recipients over the past decade. This Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement provides evidence-based, expert panel recommendations with values and preferences, and practical tips on: (1) patient selection criteria; (2) selected patient populations; and (3) post transplantation surveillance. The recommendations were developed through...
#1John Gill (UBC: University of British Columbia)H-Index: 55
#2Greg Knoll (Ottawa Hospital Research Institute)H-Index: 1
Last. Jeffrey S. Zaltzman (St. Michael's Hospital)H-Index: 17
view all 6 authors...
Purpose of Review The review provides an overview of deceased donor kidney allocation in Canada.
1 CitationsSource
#2Patricia CampbellH-Index: 21
Last. Anne HalpinH-Index: 4
view all 6 authors...
3 CitationsSource
#1Anne HalpinH-Index: 4
#2Susan NahirniakH-Index: 13
Last. Jennifer ConwayH-Index: 13
view all 9 authors...
#1Olivier Aubert (Paris V: Paris Descartes University)H-Index: 6
#2Sarah Higgins (Université de Sherbrooke)H-Index: 1
Last. Alexandre Loupy (Paris V: Paris Descartes University)H-Index: 24
view all 19 authors...
Background Transplant glomerulopathy, a common glomerular lesion observed after kidney transplant that is associated with poor prognosis, is not a specific entity but rather the end stage of overlapping disease pathways. Its heterogeneity has not been precisely characterized to date. Methods Our study included consecutive kidney transplant recipients from three centers in France and one in Canada who presented with a diagnosis of transplant glomerulopathy (Banff cg score ≥1 by light microscopy),...
1 CitationsSource
#1Carrie A. Schinstock (Mayo Clinic)H-Index: 11
#2Ruth Sapir-Pichhadze (McGill University)H-Index: 2
Last. Edward S. Kraus (Johns Hopkins University)H-Index: 37
view all 18 authors...
2 CitationsSource
#1Anne Halpin (AHS: Alberta Health Services)H-Index: 3
#2Wayne Ly (U of A: University of Alberta)
Last. Patricia Campbell (AHS: Alberta Health Services)H-Index: 21
view all 6 authors...
Aim Flow cytometry crossmatch (FCXM) is used to assess pre-transplant immunologic risk. Each laboratory must establish FCXM positive thresholds but the method to do so is not standardized. Many factors affect FCXM and its interpretation. Our aim was to compare methods of calculating FCXM thresholds and evaluate the impact of cell source and pronase. Methods Threshold study (TS) data were collected by FCXM with healthy control sera negative for HLA antibodies (n = 24) vs pronased, negatively sele...